A Flavonoid Compound 7, 4 Dihydroxy Flavone as a Potential Therapeutic for the Treatment and Management of EoE
Maskey A, Wang Z, Chen X, Dunkin D, Soffer G, Yuan Q, Li X. A Flavonoid Compound 7, 4 Dihydroxy Flavone as a Potential Therapeutic for the Treatment and Management of EoE. The FASEB Journal 2022, 36 DOI: 10.1096/fasebj.2022.36.s1.r4598.Peer-Reviewed Original ResearchLevels of TNFManagement of EoEIL-6Biopsy samplesAbnormal bowel movementsProlonged steroid useDihydroxy flavonesHigh relapse rateRisk of cancerAGE-RAGE pathwayHigh response rateSignificant reductionTraditional Chinese medicine practiceEase of administrationPathway analysisDietary eliminationOral steroidsSystemic steroidsAbdominal painBowel movementsEsophageal dysfunctionGI symptomsMaintenance therapyEosinophilic inflammationGastrointestinal refluxClinical experience with sesame oral immunotherapy and a quality-of-life assessment
You L, Soffer G, Factor J. Clinical experience with sesame oral immunotherapy and a quality-of-life assessment. Journal Of Food Allergy 2022, 4: 1-9. PMID: 39021386, PMCID: PMC11250642, DOI: 10.2500/jfa.2022.4.220003.Peer-Reviewed Original ResearchOral immunotherapyRespiratory reactionsMaintenance therapyGastrointestinal reactionsSesame allergyCutaneous reactionsFood Allergy QualityFurther prospective studiesYears of ageQuality of lifeFood-related anxietyAdverse eventsPatient chartsProspective studyLife QuestionnaireAdverse reactionsAllergic reactionsFemale genderClinical experiencePatientsDietary limitationsTherapyPrivate practiceU.S. populationOdds